Oncotarget

Research Papers:

Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis

Hanfeng Guan _, Linka Xie, Thomas Wirth and Alexey Ushmorov

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:36854-36864. https://doi.org/10.18632/oncotarget.9210

Metrics: PDF 1646 views  |   HTML 2181 views  |   ?  


Abstract

Hanfeng Guan1,2, Linka Xie3, Thomas Wirth2, Alexey Ushmorov2

1Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

2Institute of Physiological Chemistry, University of Ulm, Ulm, Germany

3Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Correspondence to:

Linka Xie, e-mail: [email protected]

Alexey Ushmorov, e-mail: [email protected]

Keywords: classical Hodgkin lymphoma (cHL), TCF3/E2A, cell death

Received: April 22, 2015    Accepted: April 25, 2016    Published: May 6, 2016

ABSTRACT

Although Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL) derived from germinal or post germinal B cells, they have lost the B cell phenotype in the process of lymphomagenesis. The phenomenon can be at least partially explained by repression of B-cell-specific transcription factors including TCF3, early B-cell factor 1 (EBF1), SPI1/PU.1, and FOXO1, which are down-regulated by genetic and epigenetic mechanisms. The unique phenotype has been suspected to be advantageous for survival of HRS cells. Ectopic expression of some of these transcription factors (EBF1, PU.1, FOXO1) indeed impaired survival of cHL cells. Here we show that forced expression of TCF3 causes cell death and cell cycle arrest in cHL cell lines. Mechanistically, TCF3 overexpression modulated expression of multiple pro-apoptotic genes including BIK, APAF1, FASLG, BOK, and TNFRSF10A/DR4. We conclude that TCF3 inactivation contributes not only to extinguishing of B cell phenotype but also to cHL oncogenesis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9210